CorrespondenceSevere left ventricular hypertrophy and marked cardiac fibrosis in Danon disease
Section snippets
Author disclosures
The author and co-authors have no disclosures to make relating to this manuscript.
Conflict of interest
The authors report no relationships that could be construed as a conflict of interest.
References (13)
- et al.
Natural history of Danon disease
Genet. Med.
(2011) - et al.
Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease)
Neuromuscul. Disord.
(2005) - et al.
Lysosomal glycogen storage disease with normal acid maltase
Neurology
(1981) - et al.
Danon disease: focusing on heart
J. Hum. Genet.
(2012) - et al.
End-stage cardiac disease as an initial presentation of systemic myopathies: case series and literature review
J. Child Neurol.
(2010) - et al.
Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey
Heart
(2004)
There are more references available in the full text version of this article.
Cited by (0)
Crown Copyright © 2016 Published by Elsevier Ireland Ltd. All rights reserved.